Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrik Forrer

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2003
Designed to be stable: crystal structure of a consensus ankyrin repeat proteinAndreas Kohl, H Kaspar Binz, Patrik Forrer, et al.
Journal of Molecular Biology|November 9, 2010
Her2-specific multivalent adapters confer designed tropism to adenovirus for gene targetingBirgit Dreier, Galina Mikheeva, Natalya Belousova, et al.
Nature Biotechnology|April 21, 2004
High-affinity binders selected from designed ankyrin repeat protein librariesH Kaspar Binz, Patrick Amstutz, Andreas Kohl, et al.
The Journal of Biological Chemistry|April 27, 2005
Intracellular kinase inhibitors selected from combinatorial libraries of designed ankyrin repeat proteinsPatrick Amstutz, H Kaspar Binz, Petra Parizek, et al.
Structure (London, England : 1993)|August 9, 2005
Allosteric inhibition of aminoglycoside phosphotransferase by a designed ankyrin repeat proteinAndreas Kohl, Patrick Amstutz, Petra Parizek, et al.
The Journal of Biological Chemistry|November 18, 2021
Thermostable designed ankyrin repeat proteins (DARPins) as building blocks for innovative drugsJohannes Schilling, Christian Jost, Ioana Mariuca Ilie, et al.
Protein Engineering, Design & Selection : PEDS|November 1, 2017
Half-life extension using serum albumin-binding DARPin® domainsDaniel Steiner, Frieder W Merz, Ivo Sonderegger, et al.
Kidney International|October 9, 2003
PDZK1: I. a major scaffolder in brush borders of proximal tubular cellsSerge M Gisler, Sandra Pribanic, Desa Bacic, et al.
The Journal of Allergy and Clinical Immunology|March 20, 2014
Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cellsAlexander Eggel, Günther Baravalle, Gabriel Hobi, et al.
Angiogenesis|September 18, 2012
Highly potent VEGF-A-antagonistic DARPins as anti-angiogenic agents for topical and intravitreal applicationsAndreas Stahl, Michael T Stumpp, Anja Schlegel, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2003
Designed to be stable: crystal structure of a consensus ankyrin repeat proteinAndreas Kohl, H Kaspar Binz, Patrik Forrer, et al.
Journal of Molecular Biology|November 9, 2010
Her2-specific multivalent adapters confer designed tropism to adenovirus for gene targetingBirgit Dreier, Galina Mikheeva, Natalya Belousova, et al.
Nature Biotechnology|April 21, 2004
High-affinity binders selected from designed ankyrin repeat protein librariesH Kaspar Binz, Patrick Amstutz, Andreas Kohl, et al.
The Journal of Biological Chemistry|April 27, 2005
Intracellular kinase inhibitors selected from combinatorial libraries of designed ankyrin repeat proteinsPatrick Amstutz, H Kaspar Binz, Petra Parizek, et al.
Structure (London, England : 1993)|August 9, 2005
Allosteric inhibition of aminoglycoside phosphotransferase by a designed ankyrin repeat proteinAndreas Kohl, Patrick Amstutz, Petra Parizek, et al.
The Journal of Biological Chemistry|November 18, 2021
Thermostable designed ankyrin repeat proteins (DARPins) as building blocks for innovative drugsJohannes Schilling, Christian Jost, Ioana Mariuca Ilie, et al.
Protein Engineering, Design & Selection : PEDS|November 1, 2017
Half-life extension using serum albumin-binding DARPin® domainsDaniel Steiner, Frieder W Merz, Ivo Sonderegger, et al.
Kidney International|October 9, 2003
PDZK1: I. a major scaffolder in brush borders of proximal tubular cellsSerge M Gisler, Sandra Pribanic, Desa Bacic, et al.
The Journal of Allergy and Clinical Immunology|March 20, 2014
Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cellsAlexander Eggel, Günther Baravalle, Gabriel Hobi, et al.
Angiogenesis|September 18, 2012
Highly potent VEGF-A-antagonistic DARPins as anti-angiogenic agents for topical and intravitreal applicationsAndreas Stahl, Michael T Stumpp, Anja Schlegel, et al.
Pageof 2